Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours.
Br J Cancer
; 126(2): 310, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-34931042
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Br J Cancer
Year:
2022
Document type:
Article
Affiliation country:
Australia